Log In
Print this Print this

Onexton Gel, clindamycin phosphate/benzoyl peroxide

  Manage Alerts
Collapse Summary General Information
Company Valeant Pharmaceuticals International Inc.
DescriptionFixed combination of 1.2% clindamycin phosphate and 3.75% benzoyl peroxide gel
Molecular Target Ribosomal 50S subunit
Mechanism of ActionRibosomal 50S subunit inhibitor
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentApproved
Standard IndicationAcne
Indication DetailsTreat acne vulgaris
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today